MedPath

Hypothermia for Encephalopathy in Low Income Countries-Feasibilty

Not Applicable
Completed
Conditions
Neonatal Encephalopathy
Interventions
Device: Tecotherm-HELIX
Registration Number
NCT01760629
Lead Sponsor
Thayyil, Sudhin
Brief Summary

Whole body cooling improves survival with normal neurological outcome after neonatal encephalopathy in high-income countries. However, cooling equipments used in the high-income countries are expensive and unsuitable for wider use in low and middle-income countries (LMIC). We had previously conducted a randomised controlled trial of whole body cooling using phase changing material in south India. Although cooling was provided, there were wide temperature fluctuations.

Aim: To examine efficacy of the low technology cooling equipment (Tecotherm-HELIX) in administering effective and stable whole body cooling in encephalopathic infants.

Methods: After informed parental consent (and ethical approvals), we will administer 72 hours of whole body cooling (rectal temperature 33 to 34C) to a total 50 encephalopathic infants (aged \<6 hours) admitted to the neonatal units at Calicut Medical College and Madras Medical College, over a six month period. To induce cooling, the infants will be kept on the cooling mattress. Temperature will be continuously measured for 80 hours using a rectal probe connected to a digital data logger.

The primary outcome will be the effective cooling time i.e. percentage of time (95% CI) for which the temperature remains between 33 to 340C during the intended cooling period.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
62
Inclusion Criteria
  1. Age < 6 hours, Birth-weight >1.8, Gestation >36 weeks
  2. Need for resuscitation at birth and 5 minute Apgar score <6 (in born babies) or Lack of cry by 5 minutes of age (for out-born babies)
  3. Evidence of encephalopathy on clinical examination
Exclusion Criteria
  • Infants in moribound condition, where death is imminent
  • Absent heart rate at 10 minute of age
  • Major life threatening congenital malformation
  • Lack of cooling equipment
  • Lack of parental or physician consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Cooling armTecotherm-HELIXWhole body cooling to 33 to 34 C rectal temperature
Primary Outcome Measures
NameTimeMethod
Feasibility of cooling72 hours

To examine feasibility of whole body cooling within six hours of birth in infants with neonatal encephalopathy

Secondary Outcome Measures
NameTimeMethod
Short term morbidity2 weeks

Short-term neonatal morbidity - Hypotension requiring inotropes, cardiac arrhythmias (other than bradycardia), coagulopathy/thrombocytopenia requiring blood products, respiratory failure requiring ventilatory support, seizures, and subcutaneous fat necrosis.

Trial Locations

Locations (3)

Calicut Medical College

🇮🇳

Calicut, India

Manipal Hospital

🇮🇳

Bangalore, India

Institute of Child Health, Madras Medical College

🇮🇳

Chennai, India

© Copyright 2025. All Rights Reserved by MedPath